I don't check Google Finance very often, but the site has a link to Cerbat Gem, which posted that the short interest is up as of mid Sept to 10.2% of shares. The site also summarizes the number of inst. investors who have added to their position. If we have a positive quarter, I suspect that there will be something of a short squeeze to cover. Find the link on Google Finance when you enter NEO.
Still working (for now). I'll still post here when there's something to say. Keep the faith, next Q will be telling about whether the transition has been mostly completed and the sales staff back to getting new customers.
A truly naive and stupid opinion. Regaining sensory functioning is a HUGE win for SCI patients as they can better monitor their skin status, be better aware of bowel and bladder status, and regain quality of life through improved sexual functioning, I'm a rehab doctor and KNOW that this is a huge win for SCI patients and approval is almost guaranteed now. Patients will line up for this procedure as is, and this is just the start. The scaffolding will now be used to set the stage for stem cell therapies as well as Olfactory sheathing cell implantation.
The devil will be in the details with regard to specific reimbursements, but the overall 1.55% OPPS rate increase is a plus. Given the draconian policies from the federal government, driving down reimbursement through the sequester and overt changes due to ACA, any changes that would resolve these (I am hoping for some resolution of the sequester) will go right to our bottom line.
If memory serves, the NEO prostate test uses technology from HDVY, so there will likely be some level of royalty to HDVY should the test come to market. The details of this royalty structure were not published to my knowledge, but ANY revenue stream to HDVY will revive the share price to some degree. That said, I've posted on the HDVY board and here that the company is a basket case and is not a real, functioning company in the sense that they continue to generate products. If the test does come to market, I will be exiting my HDVY position with relief.
This is NOT a stock to trade on technicals unless you are looking at POG technicals. The move since Brexit has been rock solid and will likely continue to move north and settle close to $1400/oz much more quickly than I had expected. Just wait until the actual Brexit starts unwinding.
Mgmt would have had to warn if there were problems with the quarter and they don't miss doing things like that. In addition, the analysts have been pushing up the estimates and my listen to the last CC led me to believe that we will again surprise on the upside. There are market forces working over the last couple of days that require some investors to exit some positions to cover others and the down wind may have caught us up in this to some degree. NEO is so young and "unproven" (at least to the uninitiated) that they may be easily left out of core positions. I agree that it is a good time to buy. I traded some of my gold stock position to buy more on the last dip, may do the same again if gold continues to move up (and my gold co. with it.) Load up now, after the next CC, I don't see us going below $10 and movement may be well north of that.
Now, let's see what the lonely shorty on this board has to say (as if we don't know.)
This looks like a bear attack, today. Of course, only time will tell, but the stock hasn't had anything like this in the past, and volume suggests that someone wants to accumulate the stock at a price much cheaper than it has been.
We just broke below a technical pivot of $8.64, clearing the way for a new technical support at $8. Not what I was expecting to happen. Doesn't help that this is happening 5 days before the end of the quarter.
Have to disagree with you on this point. If one is to believe in the investment premise here (that Au will track the inflationary cycle ahead of us), then any investment will be good if you can get in before the inflationary cycle starts in earnest. We have seen and will continue to see exponential share price increases as the POG rises.
And a good day for us as the march has, until today, had its down days. Today, however, the price fought back to near break even, a very bullish sign as far as I'm concerned. No matter to me though, I'm fully locked and loaded. For those of you sitting on the fence, this might have been the last day to get shares below $9, and soon we will see prices north of $10/share.
Take a look at NVIV. They are the only publicly traded co that has a potential product for spinal cord injury. The current report of their INSPIRE study has been very positive and they will be applying for a HDE (Humanitarian Device Exemption) for their product some time in 2017. I don't think they will be denied and the market will respond very positively to a first-to-the-market surgical intervention for SCI patients. Given the timeline, there is plenty of time to start accumulating this.